Back

Unravelling the triglycerides story: Lessons from genetics and clinical trials.

29 August 2021 (11:30 - 11:40)
Organised by:
Congress Presentation Part of: Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglycerides Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Peter Libby

Mass General Brigham, Boston (United States of America)

2 More presentations in this session

Presentation thumbnail
EPA based therapy in CAD: What do we know?
Professor L. Tokgozoglu (Ankara, TR)
Video
Presentation thumbnail
Integrating EPA based therapy in the management of residual risk.
Professor P. Steg (Paris, FR)
Video

Access the full session

Session thumbnail
Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglycerides
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Targeting triglycerides: is it worth it? lessons from recent trials
1 September 2024
thumbnail
Congress Presentation
Association between triglyceride with all-cause mortality and cardiovascular outcomes in heart failure patients: a territory-wide study in Hong Kong
20 May 2023
thumbnail
Congress Presentation
A randomized, placebo-controlled phase 3 study of plozasiran in patients with familial chylomicronemia syndrome: PALISADE - 1 year open label extension
30 August 2025
thumbnail
Congress Presentation
Triglyceride lowering after MI
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources